Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) CAO Alexander Azoy sold 4,343 shares of Arcus Biosciences stock in a transaction dated Thursday, December 18th. The shares were sold at an average price of $22.25, for a total transaction of $96,631.75. Following the sale, the chief accounting officer owned 18,531 shares of the company’s stock, […]

Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) CFO Robert Goeltz II sold 6,702 shares of the firm’s stock in a transaction dated Tuesday, December 16th. The stock was sold at an average price of $21.88, for a total value of $146,639.76. Following the completion of the sale, the chief financial officer directly owned 80,436 […]

Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) COO Jennifer Jarrett sold 9,983 shares of Arcus Biosciences stock in a transaction on Wednesday, December 17th. The stock was sold at an average price of $22.16, for a total value of $221,223.28. Following the transaction, the chief operating officer owned 193,024 shares in the company, valued […]

Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) CEO Terry Rosen sold 25,744 shares of the firm’s stock in a transaction dated Wednesday, December 17th. The shares were sold at an average price of $22.16, for a total transaction of $570,487.04. Following the completion of the sale, the chief executive officer owned 2,194,809 shares of […]

Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) CAO Alexander Azoy sold 2,376 shares of the company’s stock in a transaction that occurred on Tuesday, December 16th. The shares were sold at an average price of $21.88, for a total value of $51,986.88. Following the completion of the sale, the chief accounting officer owned 24,987 […]

Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) CEO Terry Rosen sold 28,947 shares of Arcus Biosciences stock in a transaction on Tuesday, December 16th. The shares were sold at an average price of $21.88, for a total value of $633,360.36. Following the completion of the transaction, the chief executive officer owned 2,220,553 shares in […]

Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) General Counsel Carolyn Tang sold 7,658 shares of the firm’s stock in a transaction on Tuesday, December 16th. The stock was sold at an average price of $21.88, for a total value of $167,557.04. Following the transaction, the general counsel owned 131,544 shares of the company’s stock, […]

Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) President Juan Jaen sold 11,225 shares of the stock in a transaction on Tuesday, December 16th. The stock was sold at an average price of $21.88, for a total value of $245,603.00. Following the completion of the sale, the president directly owned 355,995 shares in the company, […]